|
1
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ordás I, Eckmann L, Talamini M, Baumgart
DC and Sandborn WJ: Ulcerative colitis. Lancet. 380:1606–1619.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molodecky NA, Soon IS, Rabi DM, Ghali WA,
Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema
HW and Kaplan GG: Increasing incidence and prevalence of the
inflammatory bowel diseases with time, based on systematic review.
Gastroenterology. 142:46–54. 2012. View Article : Google Scholar
|
|
4
|
Grivennikov SI: Inflammation and
colorectal cancer: colitis-associated neoplasia. Semin
Immunopathol. 35:229–244. 2013. View Article : Google Scholar
|
|
5
|
Bernklev T, Jahnsen J, Lygren I, Henriksen
M, Vatn M and Moum B: Health-related quality of life in patients
with inflammatory bowel disease measured with the short form-36:
Psychometric assessments and a comparison with general population
norms. Inflamm Bowel Dis. 11:909–918. 2005. View Article : Google Scholar
|
|
6
|
Harpaz N and Talbot IC: Colorectal cancer
in idiopathic inflammatory bowel disease. Semin Diagn Pathol.
13:339–357. 1996.
|
|
7
|
Sandborn WJ: Azathioprine: State of the
art in inflammatory bowel disease. Scand J Gastroenterol Suppl.
225:92–99. 1998. View Article : Google Scholar
|
|
8
|
Targownik LE and Bernstein CN: Infectious
and malignant complications of TNF inhibitor therapy in IBD. Am J
Gastroenterol. 108:1835–1842; quiz 1843. 2013. View Article : Google Scholar
|
|
9
|
Álvarez P, Marchal JA, Boulaiz H, Carrillo
E, Vélez C, Rodríguez-Serrano F, Melguizo C, Prados J, Madeddu R
and Aranega A: 5-Fluorouracil derivatives: A patent review. Expert
Opin Ther Patents. 22:107–123. 2012. View Article : Google Scholar
|
|
10
|
Bielecki K, Wiedmann M, Meyer F, Kimura W
and Mössner J: Effect of 5-fluorouracil on secretion and synthesis
of pancreatic digestive enzymes: Studies in isolated pancreatic
acini and perfused pancreas derived from normal rats and from rats
with acute necrotizing pancreatitis. Pancreas. 9:518–525. 1994.
View Article : Google Scholar
|
|
11
|
Rich TA, Shepard RC and Mosley ST: Four
decades of continuing innovation with fluorouracil: Current and
future approaches to fluorouracil chemoradiation therapy. J Clin
Oncol. 22:2214–2232. 2004. View Article : Google Scholar
|
|
12
|
Chen X-L, Ciren S-Z, Zhang H, Duan LG and
Wesley AJ: Effect of 5-FU on modulation of disarrangement of
immune-associated cytokines in experimental acute pancreatitis.
World J Gastroenterol. 15:2032–2037. 2009. View Article : Google Scholar :
|
|
13
|
Luther J, Owyang SY, Takeuchi T, Cole TS,
Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala
AV, et al: Helicobacter pylori DNA decreases pro-inflammatory
cytokine production by dendritic cells and attenuates dextran
sodium sulphate-induced colitis. Gut. 60:1479–1486. 2011.
View Article : Google Scholar
|
|
14
|
Song JL, Qian Y, Li GJ and Zhao X:
Anti-inflammatory effects of kudingcha methanol extract (Ilex
kudingcha C.J. Tseng) in dextran sulfate sodium-induced ulcerative
colitis. Mol Med Rep. 8:1256–1262. 2013.PubMed/NCBI
|
|
15
|
Obermeier F, Dunger N, Strauch UG, Hofmann
C, Bleich A, Grunwald N, Hedrich HJ, Aschenbrenner E,
Schlegelberger B, Rogler G, et al: CpG motifs of bacterial DNA
essentially contribute to the perpetuation of chronic intestinal
inflammation. Gastroenterology. 129:913–27. 2005. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Bradley PP, Priebat DA, Christensen RD and
Rothstein G: Cellular and extracellular myeloperoxidase in pyogenic
inflammation. J Invest Dermatol. 78:206–209. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berndt BE, Zhang M, Chen GH, Huffnagle GB
and Kao JY: The role of dendritic cells in the development of acute
dextran sulfate sodium colitis. J Immunol. 179:6255–6262. 2007.
View Article : Google Scholar
|
|
19
|
Kitajima S, Takuma S and Morimoto M:
Changes in colonic mucosal permeability in mouse colitis induced
with dextran sulfate sodium. Exp Anim. 48:137–143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li L, Ren F, Yun Z, An Y, Wang C and Yan
X: Determination of the effects of lactoferrin in a preclinical
mouse model of experimental colitis. Mol Med Rep. 8:1125–1129.
2013.
|
|
21
|
Karrasch T and Jobin C: NF-kappaB and the
intestine: Friend or foe? Inflamm Bowel Dis. 14:114–124. 2008.
View Article : Google Scholar
|
|
22
|
Schreiber S, Nikolaus S and Hampe J:
Activation of nuclear factor kappa B inflammatory bowel disease.
Gut. 42:477–484. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rogler G, Brand K, Vogl D, Page S,
Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Schölmerich J and
Gross V: Nuclear factor kappaB is activated in macrophages and
epithelial cells of inflamed intestinal mucosa. Gastroenterology.
115:357–369. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berndt U, Bartsch S, Philipsen L, Danese
S, Wiedenmann B, Dignass AU, Hämmerle M and Sturm A: Proteomic
analysis of the inflamed intestinal mucosa reveals distinctive
immune response profiles in Crohn's disease and ulcerative colitis.
J Immunol. 179:295–304. 2007. View Article : Google Scholar
|
|
25
|
Pizarro TT and Cominelli F: Cytokine
therapy for Crohn's disease: Advances in translational research.
Annu Rev Med. 58:433–444. 2007. View Article : Google Scholar
|
|
26
|
Islam S, Hassan F, Tumurkhuu G, Ito H,
Koide N, Mori I, Yoshida T and Yokochi T: 5-Fluorouracil prevents
lipopolysaccharide-induced nitric oxide production in RAW 264.7
macrophage cells by inhibiting Akt-dependent nuclear factor-kappaB
activation. Cancer Chemother Pharmacol. 59:227–233. 2007.
View Article : Google Scholar
|
|
27
|
Melen-Mucha G, Balcerczak E, Mucha S,
Panczyk M, Lipa S and Mirowski M: Expression of p65 gene in
experimental colon cancer under the influence of 5-fluorouracil
given alone and in combination with hormonal modulation. Neoplasma.
51:319–324. 2004.PubMed/NCBI
|
|
28
|
Zhou MT, Chen BC and Sun HW: Continuous
regional arterial infusion with fluorouracil and octreotide
attenuates severe acute pancreatitis in a canine model. PLoS One.
7:e373472012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fournier BM and Parkos CA: The role of
neutrophils during intestinal inflammation. Mucosal Immunol.
5:354–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aarvak T and Natvig JB: Cell-cell
interactions in synovitis: Antigen presenting cells and T cell
interaction in rheumatoid arthritis. Arthritis Res. 3:13–17. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayden MS, West AP and Ghosh S: NF-kappaB
and the immune response. Oncogene. 25:6758–6780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keefe DM, Gibson RJ and Hauer-Jensen M:
Gastrointestinal mucositis. Semin Oncol Nurs. 20:38–47. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Azevedo OG, Oliveira RA, Oliveira BC,
Zaja-Milatovic S, Araújo CV, Wong DV, Costa TB, Lucena HB, Lima RC
Jr, Ribeiro RA, et al: Apolipoprotein E COG 133 mimetic peptide
improves 5-fluorouracil-induced intestinal mucositis. BMC
Gastroenterol. 12:352012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saegusa Y, Ichikawa T, Iwai T, Goso Y,
Okayasu I, Ikezawa T, Shikama N, Saigenji K and Ishihara K: Changes
in the mucus barrier of the rat during 5-fluorouracil-induced
gastrointestinal mucositis. Scand J Gastroenterol. 43:59–65. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pritchard DM, Potten CS and Hickman JA:
The relationships between p53-dependent apoptosis, inhibition of
proliferation, and 5-fluorouracil-induced histopathology in murine
intestinal epithelia. Cancer Res. 58:5453–5465. 1998.PubMed/NCBI
|
|
36
|
Sakai H, Sagara A, Matsumoto K, Hasegawa
S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S
and Narita M: 5-Fluorouracil induces diarrhea with changes in the
expression of inflammatory cytokines and aquaporins in mouse
intestines. PLoS One. 8:e547882013. View Article : Google Scholar : PubMed/NCBI
|
